Amphetamine Cocaine Interaction Study - 2
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00000305 |
Recruitment Status :
Terminated
(Original P.I. left the institution)
First Posted : September 21, 1999
Last Update Posted : May 18, 2012
|
Sponsor:
The University of Texas Health Science Center, Houston
Collaborators:
National Institute on Drug Abuse (NIDA)
University of Texas
Information provided by (Responsible Party):
The University of Texas Health Science Center, Houston
Tracking Information | ||||
---|---|---|---|---|
First Submitted Date ICMJE | September 20, 1999 | |||
First Posted Date ICMJE | September 21, 1999 | |||
Last Update Posted Date | May 18, 2012 | |||
Study Start Date ICMJE | Not Provided | |||
Primary Completion Date | Not Provided | |||
Current Primary Outcome Measures ICMJE | Not Provided | |||
Original Primary Outcome Measures ICMJE |
|
|||
Change History | ||||
Current Secondary Outcome Measures ICMJE | Not Provided | |||
Original Secondary Outcome Measures ICMJE | Not Provided | |||
Current Other Pre-specified Outcome Measures | Not Provided | |||
Original Other Pre-specified Outcome Measures | Not Provided | |||
Descriptive Information | ||||
Brief Title ICMJE | Amphetamine Cocaine Interaction Study - 2 | |||
Official Title ICMJE | Amphetamine Cocaine Interaction Study | |||
Brief Summary | The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology) interaction study. | |||
Detailed Description | Not Provided | |||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Phase 1 | |||
Study Design ICMJE | Primary Purpose: Treatment | |||
Condition ICMJE | Cocaine-Related Disorders | |||
Intervention ICMJE | Drug: Dextroamphetamine | |||
Study Arms ICMJE | Not Provided | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
Recruitment Information | ||||
Recruitment Status ICMJE | Terminated | |||
Enrollment ICMJE |
0 | |||
Original Enrollment ICMJE | Same as current | |||
Study Completion Date ICMJE | Not Provided | |||
Primary Completion Date | Not Provided | |||
Eligibility Criteria ICMJE | Please contact site for information. | |||
Sex/Gender ICMJE |
|
|||
Ages ICMJE | 18 Years to 45 Years (Adult) | |||
Accepts Healthy Volunteers ICMJE | No | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | United States | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number ICMJE | NCT00000305 | |||
Other Study ID Numbers ICMJE | NIDA-09262-2 P50DA009262 ( U.S. NIH Grant/Contract ) P50-09262-2 |
|||
Has Data Monitoring Committee | Yes | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | The University of Texas Health Science Center, Houston | |||
Study Sponsor ICMJE | The University of Texas Health Science Center, Houston | |||
Collaborators ICMJE |
|
|||
Investigators ICMJE |
|
|||
PRS Account | The University of Texas Health Science Center, Houston | |||
Verification Date | May 2012 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |